AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

RecruitingNAAges any - 1 YearAllChildren's Hospital of Philadelphia
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of the study is to assess the impact of a personalized intubation planning tool, the Personalized INtubation Safety (PINS) Bundle on intubation procedural safety and clinical outcomes among patients intubated in the neonatal intensive care unit (NICU) setting.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Infants undergoing tracheal intubation in the neonatal intensive care unit (NICU) Exclusion Criteria: Endotracheal tube exchanges, as this represents a distinct procedure.
๐Ÿ’Š

What it tests

  • Personalized Intubation Safety (PINS) Bundle
๐Ÿ“

Where

8 sites
University of Arkansas Medical Sciences
Little Rock, United States
University of Colorado - Denver
Denver, United States
Yale-New Haven Hospital
New Haven, United States
Dartmouth-Hitchcock Clinic
Lebanon, United States
WakeMed Health & Hospitals
Raleigh, United States
Penn State Milton S. Hershey Medical Center
Hershey, United States
University of Washington
Seattle, United States
CHU Sainte-Justine
Montreal, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy